52 providers · in our published order

Best online GLP-1 programs 2026

Costs, care and plan terms for 52 providers.

Embody$49/moTrimRxFrom $179SnagRx$59/mo
Compare prices for all 52 providers

How we make money: we may earn a commission when you sign up through a partner link. Affiliate disclosure.

Cheapest compounded GLP-1s

Lowest recorded semaglutide, partner programs

Paid links, sorted by recorded monthly or one-month subtotal. Not a complete cost, and other programs may be lower.

Embody$79/moCoreAge Rx$79/moStrut Health$129/mo
Sort all 52 providers by price

Partner picks

Partner programs, in published order

See all 52

Paid links. The order is not a score.

Embody

Compounded

Semaglutide

$49/mo

12-month plan, $79/mo monthly

Tirzepatide

$99/mo

12-month plan, $129/mo monthly

  • Recorded as available in 48 states
  • Consultation on record: included
Visit Embody Embody reviews

TrimRx

Compounded

Semaglutide

From $179

seller says GLP-1, term not stated

Tirzepatide

From $279

seller says GLP-1 + GIP, term not stated

  • Recorded as available in 45 states
  • Consultation on record: free
Visit TrimRx TrimRx reviews

The short answer

Which online GLP-1 program is best?

It depends on the medication, the plan length you can commit to and whether you need insurance. We do not score programs or name a single winner. Start from what is recorded:

  • Lowest recorded semaglutide subtotal in the full directory: Embody, $79/mo.
  • Lowest recorded tirzepatide subtotal in the full directory: Embody, $129/mo.
  • Records reporting insurance: 7. Brand-name medication listed: 23.

Compounded drugs are not FDA-approved. FDA guidance. Every recorded field and limitation.

Semaglutide and tirzepatide were first developed for type 2 diabetes. Online programs now prescribe them for weight loss, and 11 of our 52 provider records carry an FDA warning letter. The provider you choose matters, so we report each one's safety, transparency, cost, support and access. See our methodology.

Our research

This comparison is built from our records of 52 GLP-1 telehealth providers, covering both FDA-approved brand-name drugs and compounded options.

Market snapshot (updated Nov 11, 2026): across 21 providers with a recorded subtotal, the lowest compounded semaglutide subtotal is $79/month and the lowest compounded tirzepatide subtotal is $129/month, tracked in our GLP-1 Price Index. On efficacy, semaglutide produced about 15% average body-weight loss in the STEP 1 trial (New England Journal of Medicine, 2021) and tirzepatide up to about 21% in SURMOUNT-1 (NEJM, 2022). Those trials tested the approved drugs, not compounded versions.

Provider record (paid link)

Embody

Lists compounded GLP-1 medication. Recorded as available in 48 states.

from $49/mo on a 12-month plan; $79/mo semaglutide, $129/mo tirzepatide, monthly plan

Visit Embody Read full review

Every program

GLP-1 providers at a glance

Recorded medication and program subtotals are not verified all-in costs. Labs, dose changes and other fees may be unknown. See pharmacy, clinician and cancellation evidence.

52 of 52 records, in our provider order

Recorded prices by provider, with a paid link per row. Unknown costs are not free.
ProgramPrice
Embody

Semaglutide, 12-month plan, $79/mo monthly · Tirzepatide $99/mo

$49/moVisit site
TrimRx

Semaglutide, seller says GLP-1, term not stated · Tirzepatide From $279

From $179Visit site
Oak Longevity

Semaglutide, 12-month plan · Tirzepatide From $185/mo

From $119/moVisit site
Gala Health

Semaglutide, drug and term not stated · Tirzepatide From $69/mo

From $69/moVisit site
MEDVi

Semaglutide, monthly plan

$199/moVisit site
SkinnyRx

Semaglutide, first month, renewal not published · Tirzepatide $99

$99Visit site

Compounded medications are not FDA-approved. FDA guidance. Insurance acceptance is not a promise of drug coverage. For Medicare eligibility and terms, see CMS's GLP-1 Bridge information.

See if your plan covers GLP-1s

Pick your carrier. We'll show coverage status and match you with providers that accept it.

Pick your carrier below to see coverage instantly:

Or skip ahead and see my options →

Coverage summaries based on common plan formularies. Always confirm with your specific plan: call the member services number on your ID card.

Compare costs and evidence

Review medication prices, required care costs, billing commitments, pharmacy-license evidence and cancellation terms.

Open the decision table
Visit Embody

How this list is ordered

Programs follow our published order. It is not a score or an award. Partner picks and Visit provider buttons are paid links.

Editorial standardsSources and limitations

Check the sources and any dated review information on the individual page. See our standards

Eduard Cristea
Eduard Cristea
Published: |Updated:

Methodology

What do our program reviews cover?

Each review reports the same five areas from the provider's record, without a score. See the full methodology.

We earn affiliate commissions from some providers, disclosed on every page. No provider can pay to fake safety, licensing, or hide a review's downsides.

Safety
Drug type, the FDA record, and what to check about the prescriber and pharmacy.
Transparency
Whether a price comes with a plan term and a source, and what is not recorded.
Cost
Recorded monthly and prepaid prices, kept apart, and fees we could find.
Support
What the seller says about clinician access and messaging, plus the customer record.
Access
States recorded, insurance acceptance and cancellation terms.

How to use this comparison

The table uses the same provider records as our review pages. Use the recorded costs, billing terms and source details to compare programs for your circumstances.

Compare the medication and billing term first, then add required program fees, consultations, labs, shipping and any dose-related charges. A medication-plus-program subtotal is not a complete cost when another charge is not recorded. A prepaid plan's monthly equivalent is not a cancellable month-to-month rate. Our saved notes may contain conflicting provider prices; each review page identifies them.

Provider descriptions of medical support, service area and cancellation are recorded claims. They are not an independent license audit. A commercial certification or an FDA registration is not a substitute for checking the actual dispensing pharmacy with the state board. FDA license-check guidance.

Ask for a written quote for your prescribed dose, the pharmacy's name and license number, the prescribing clinician's name and license, your state's eligibility, the renewal price, and cancellation and refund terms before paying. Eligibility and treatment decisions belong with a licensed clinician. Read our full methodology.

Safety

What safety risks should you know?

The labels list stomach side effects as most common, and serious risks that need a clinician's attention. FDA adds its own concerns about unapproved and compounded versions.

  • Common side effects: nausea, diarrhea, vomiting, constipation and abdominal pain are among the most common on both the Wegovy label and the Zepbound label.
  • Boxed warning: both labels carry a boxed warning on the risk of thyroid C-cell tumors. It is not known whether these drugs cause them in humans. They are contraindicated with a personal or family history of medullary thyroid carcinoma or with Multiple Endocrine Neoplasia syndrome type 2.
  • Other label warnings: acute pancreatitis, gallbladder disease, severe gastrointestinal reactions, acute kidney injury from volume depletion, serious hypersensitivity reactions, and pulmonary aspiration during anesthesia or deep sedation. Tell your clinician about any planned surgery.
  • Compounded and unapproved versions: FDA says they do not undergo its review for safety, effectiveness or quality. It reports adverse events, some requiring hospitalization, possibly tied to dosing errors with compounded semaglutide, and says compounded drugs should only be used when an FDA-approved drug cannot meet a patient's needs. It has issued warning letters to stop the distribution of illegally marketed semaglutide and tirzepatide.
  • Counterfeits: FDA is aware of counterfeit Ozempic in the US supply, and advises getting a prescription from your doctor and using a state-licensed pharmacy.
  • Heart risk: the Wegovy label includes an indication to reduce major cardiovascular events in adults with established cardiovascular disease and obesity or overweight.

This is a summary, not medical advice. Read the full label with your clinician.

Safety before you choose

Read our side effects guide, the differences between compounded and brand-name GLP-1s and the scam checker. Named checks: is Direct Meds legit, Hers, Noom. Brand comparison: Ozempic vs Wegovy. FDA's page lists its concerns with unapproved GLP-1 drugs.

Frequently asked questions

How much do online GLP-1 programs cost per month?

Recorded monthly-plan subtotals among active listings run from $79 to $399 a month. These are partial subtotals: consultation, labs, dose changes and shipping may be separate, and prepaid equivalents are not monthly prices. Recorded brand-name list prices run $1,028 to $1,350 a month before insurance.

Is compounded semaglutide or tirzepatide FDA-approved?

No. Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness or quality before marketing. FDA recommends obtaining a prescription and using a state-licensed pharmacy.

Is compounded semaglutide safe?

FDA does not review compounded semaglutide for safety, effectiveness or quality before marketing. It reports adverse events, some requiring hospitalization, that may be related to dosing errors, and it has issued warning letters to stop the distribution of illegally marketed semaglutide and tirzepatide. If you and your clinician choose a compounded option, confirm the pharmacy is state-licensed.

Do online GLP-1 programs take insurance?

7 of the 52 provider records report accepting insurance. Confirm your plan and what it covers with the provider.

How do I check that an online GLP-1 program is legitimate?

Ask for the dispensing pharmacy's name and license number and check it with the state board, ask for the prescriber's name and state license, read recent customer reviews, check for FDA warning letters, and get the renewal price and refund terms in writing before paying.

Does Medicare cover GLP-1 weight loss drugs?

For eligible people, yes, through a temporary program. Since July 1, 2026, the Medicare GLP-1 Bridge has covered Foundayo, Wegovy (injection or tablet) and Zepbound KwikPen at a $50 copay for a one-month supply, through December 31, 2027. BMI and other rules apply, and some conditions and plan types are excluded.

What happens if I stop taking a GLP-1?

Weight can return. Zepbound's label describes a trial in which people who kept taking it after 36 weeks did better on weight over the next 52 weeks than people switched to placebo. Discuss a long-term plan with your clinician before starting, and do not stop or change a dose without talking to them.

Not sure which program is right for you?

Answer a few questions about your budget, insurance and medication, and see programs to compare.

Take the quiz

Embody (paid link)

from $49/mo, 12-month plan

Visit Embody